PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 139 filers reported holding PRINCIPIA BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $296,325,000 | +0.8% | 4,956,097 | +0.1% | 0.03% | -19.5% |
| Q1 2020 | $294,006,000 | +9.1% | 4,951,265 | +0.7% | 0.04% | +36.7% |
| Q4 2019 | $269,405,000 | +165.3% | 4,917,932 | +36.8% | 0.03% | +150.0% |
| Q3 2019 | $101,539,000 | -14.5% | 3,595,562 | +0.4% | 0.01% | -14.3% |
| Q2 2019 | $118,819,000 | -2.4% | 3,579,968 | +0.0% | 0.01% | -6.7% |
| Q1 2019 | $121,713,000 | +289.1% | 3,579,788 | +213.4% | 0.02% | +275.0% |
| Q4 2018 | $31,281,000 | +51.0% | 1,142,071 | +61.1% | 0.00% | +100.0% |
| Q3 2018 | $20,713,000 | – | 708,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,625,713 | $76,723,000 | 13.96% |
| Sofinnova Investments, Inc. | 2,059,146 | $59,556,000 | 5.31% |
| Cormorant Asset Management, LP | 1,486,898 | $43,447,000 | 2.82% |
| RTW INVESTMENTS, LP | 644,448 | $17,369,000 | 1.04% |
| Orbimed Advisors | 2,605,713 | $76,139,000 | 0.92% |
| BVF INC/IL | 240,000 | $7,013,000 | 0.62% |
| Monashee Investment Management LLC | 62,500 | $1,826,000 | 0.39% |
| DC Investments Management, LLC | 18,376 | $537,000 | 0.36% |
| Baker Brothers Advisors | 1,787,807 | $52,240,000 | 0.34% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 248,626 | $7,265,000 | 0.22% |